EF
ALNY icon

Empowered Funds’s Alnylam Pharmaceuticals ALNY Stock Holding History

Empowered Funds’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
4,355
-1,055
-20% -$318K 0.01% 1369
2026
Q1 		$1.79M Sell
5,410
-14,021
-72% -$4.77M 0.01% 1160
2025
Q4 		$7.73M Buy
19,431
+15,146
+353% +$6.7M 0.13% 181
2025
Q3 		$1.95M Buy
4,285
+1,432
+50% +$583K 0.02% 931
2025
Q2 		$930K Sell
2,853
-3,048
-52% -$843K 0.01% 1100
2025
Q1 		$1.59M Sell
5,901
-1,729
-23% -$444K 0.02% 839
2024
Q4 		$1.8M Buy
7,630
+566
+8% +$149K 0.03% 779
2024
Q3 		$1.94M Buy
7,064
+5,362
+315% +$1.4M 0.03% 686
2024
Q2 		$414K Sell
1,702
-12,147
-88% -$1.92M 0.01% 1106
2024
Q1 		$2.07M Buy
13,849
+524
+4% +$87.4K 0.04% 603
2023
Q4 		$2.55M Buy
13,325
+11,873
+818% +$2.02M 0.06% 430
2023
Q3 		$257K Buy
1,452
+134
+10% +$25.6K 0.01% 1092
2023
Q2 		$250K Sell
1,318
-17
-1% -$3.37K 0.01% 1014
2023
Q1 		$267K Buy
+1,335
New +$281K 0.02% 467
2022
Q4 		– Sell
-1,031
Closed -$220K – 446
2022
Q3 		$206K Buy
+1,031
New +$197K 0.02% 308

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's ALNY Position: Q2 2026 in Review

Empowered Funds reduced its Alnylam Pharmaceuticals (ALNY) stake by 20% in Q2 2026, selling an estimated $318K and leaving 4,355 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1369.

Empowered Funds first reported a position in ALNY in Q3 2022 and has held it in 15 quarters since. The position peaked at $7.73M in Q4 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Empowered Funds held 4,355 shares of Alnylam Pharmaceuticals worth $1.31M as of Q2 2026.
  • Empowered Funds sold 1,055 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $318K.
  • Alnylam Pharmaceuticals made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1369 holding.
  • Empowered Funds first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Empowered Funds's Alnylam Pharmaceuticals position peaked at $7.73M in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.